![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Previsioni di mercato della diagnostica per il cancro al cervello nell\'Asia del Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipo diagnostico (test di imaging, puntura lombare, biopsia, test molecolari e altri); Tipo di cancro (neuroma acustico, astrocitoma, craniofaringiomi, ganglioneuromi, glioblastoma multiforme, meningiomi, ependimomi e altri); Utente finale (ospedali, cliniche specialistiche, centri chirurgici ambulatoriali e altri)
Introduzione al mercato
I tumori al cervello sono causati dalla crescita extracellulare delle cellule nel cervello che causano i tumori. Il tumore comprende tumori cerebrali primari e tumori cerebrali secondari. I tumori cerebrali primari si formano nel cervello e non si diffondono ad altre parti del corpo, mentre i tumori secondari, noti anche come metastasi, sono quei tumori che hanno avuto inizio in un\'altra parte del corpo. I tumori al cervello sono classificati in 40 tipi principali, ulteriormente classificati in due gruppi principali: benigni, ovvero a crescita lenta e con minore possibilità di diffusione, e maligni, ovvero cancerosi e con maggiore probabilità di diffusione.
< p>Pertanto, si prevede che l\'aumento della prevalenza del cancro al cervello creerà una domanda significativa per la diagnostica del cancro al cervello nei prossimi anni, che si prevede guiderà ulteriormente il mercato della diagnostica del cancro al cervello.L\'epidemia ha gravemente colpito ha colpito l’industria del turismo medico nell’Asia del Pacifico e ha imposto interruzioni della catena di approvvigionamento; Inoltre, i paesi a basso reddito si trovano ad affrontare ulteriori sfide dovute alla carenza di infrastrutture sanitarie, alle restrizioni imposte dagli ospedali ai fornitori, alla diminuzione della domanda di dispositivi diagnostici per il cancro al cervello e altro. Misure restrittive sono state adottate in Corea del Sud, Malesia, Singapore, Filippine e India per prevenire la trasmissione della malattia. Si prevede che queste misure restrittive avranno un impatto sulla catena di approvvigionamento e sulla disponibilità di dispositivi medici in questi paesi. Ha avuto ripercussioni sui redditi disponibili e ha provocato anche disoccupazione. Inoltre, le strategie aziendali come acquisizioni, fusioni e partnership sono influenzate negativamente dall’imposizione del blocco completo. Si prevede che tali ostacoli alle attività commerciali ostacolino l\'adozione di vari sistemi sanitari tecnologicamente avanzati, compresa la diagnostica del cancro al cervello.
Panoramica e dinamiche del mercato
Si prevede che il mercato della diagnostica del cancro al cervello nell\'Asia del Pacifico crescerà da 178,6 milioni di dollari nel 2021 a 178,6 milioni di dollari nel 2021 551,4 milioni entro il 2028; si stima che crescerà a un CAGR del 17,5% dal 2021 al 2028. Il termine \"tumore cerebrale primario\" si riferisce a un tumore che inizia nel cervello. Il cancro del cervello e del sistema nervoso è la decima causa di mortalità negli uomini e nelle donne. Nel corso della vita di una persona, le probabilità di avere questa forma di tumore sono inferiori all\'1%. La maggior parte dei tumori maligni primari del sistema nervoso centrale (SNC) sono tumori cerebrali, che rappresentano dall’85% al 90% di tutti i casi. I tumori al cervello possono essere fatali, avere un grave impatto sulla qualità della vita e, in definitiva, trasformare la vita di un paziente e della sua famiglia. Inoltre, la diagnosi precoce dei tumori offre spesso più opzioni terapeutiche. La tecnologia di imaging avanzata può individuare la posizione dei tumori al cervello. Gli strumenti diagnostici includono la risonanza magnetica (MRI) e la tomografia computerizzata (TC o TAC). La risonanza magnetica intraoperatoria può essere utilizzata anche per guidare la biopsia tissutale e la resezione del tumore durante l\'intervento chirurgico. La spettroscopia di risonanza magnetica (MRS) viene utilizzata per esaminare le caratteristiche chimiche dei tumori. Pertanto, l’aumento della prevalenza del cancro al cervello richiede fortemente strumenti diagnostici per il cancro al cervello.
Segmenti chiave del mercato
In termini di tipo diagnostico, il segmento dei test per immagini ha rappresentato la quota maggiore del mercato della diagnostica del cancro al cervello nell’Asia del Pacifico nel 2020. In termini di tipo di cancro, il segmento del glioblastoma multiforme ha rappresentato la quota maggiore del mercato della diagnostica del cancro al cervello nell’Asia del Pacifico in 2020. In termini di utenti finali, nel 2020 il segmento ospedaliero ha rappresentato la quota maggiore del mercato della diagnostica per il cancro al cervello nell\'area Asia-Pacifico.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie citate per la preparazione di questo rapporto sul cancro al cervello mercato della diagnostica nell\'Asia del Pacifico sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. e Neusoft Medical Systems.
Motivi rapporto per acquistare
- Comprendere il panorama del mercato della diagnostica per il cancro al cervello nell\'Asia del Pacifico e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno
- Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato della diagnostica del cancro al cervello nell\'Asia del Pacifico
- Pianifica in modo efficiente fusioni e acquisizioni e accordi di partnership nell\'Asia del Pacifico Diagnostica del cancro al cervello mercato identificando segmenti di mercato con le vendite probabili più promettenti
- Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi perspicace e completa delle prestazioni di mercato di vari segmenti del mercato della diagnostica del cancro al cervello dell\'Asia Pacifico
- Ottenere Previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione Asia-Pacifico.
Segmentazione del mercato della diagnostica per il cancro al cervello nell\'Asia Pacifico
Per tipo diagnostico
- Test di imaging
- MRI
- TAC
- PET
- Biopsia
- Test molecolari
- Puntura lombare
- Altri
Per tipo di cancro
< ul>
Da Utente finale
- Ospedali
- Cliniche specializzate
- Centri chirurgici ambulatoriali
- Altri
Per Paese
- Asia Pacifico
- Cina
- Giappone
- India
- Corea del Sud
- Australia
- Resto dell\'Asia Pacifico
Aziende citate
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc .
- Koninklijke Philips NV
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 Asia Pacific Brain Cancer Diagnostics Market – By Country
2. Asia Pacific Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Market Opportunities
5.3.1 Increasing Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.5 Impact Analysis
6. Brain Cancer Diagnostics Market – Asia Pacific Analysis
6.1 Asia Pacific Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Asia Pacific: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.3 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 China: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.3.2.1 China: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.3.3 China: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.3.4 China: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.4 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Japan: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.4.2.1 Japan: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.4.3 Japan: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.4.4 Japan: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.5 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 India: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.5.2.1 India: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.5.3 India: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.5.4 India: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.6 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Australia: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.6.2.1 Australia: Brain Cancer Diagnostics Market, By Imaging Tests, 2019–2028 (USD Million)
10.1.6.3 Australia: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.6.4 Australia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.7 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.7.2.1 South Korea: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.7.3 South Korea: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.7.4 South Korea: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.8 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.8.2.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.8.3 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.8.4 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Brain Cancer Diagnostics Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)
Table 11. India: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Brain Cancer Diagnostics Market, By Imaging Tests – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments in the Brain Cancer Diagnostics Market
Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 27. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Asia Pacific Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - Asia Pacific PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution